Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.
Publication
, Journal Article
Jeong, Y-H; Abadilla, KA; Tantry, US; Park, Y; Koh, J-S; Kwak, CH; Hwang, J-Y; Gurbel, PA
Published in: J Thromb Haemost
June 2013
Duke Scholars
Published In
J Thromb Haemost
DOI
EISSN
1538-7836
Publication Date
June 2013
Volume
11
Issue
6
Start / End Page
1194 / 1197
Location
England
Related Subject Headings
- Ticlopidine
- Polymorphism, Single Nucleotide
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Pilot Projects
- Pharmacogenetics
- Percutaneous Coronary Intervention
- Odds Ratio
- Multivariate Analysis
- Middle Aged
Citation
APA
Chicago
ICMJE
MLA
NLM
Jeong, Y.-H., Abadilla, K. A., Tantry, U. S., Park, Y., Koh, J.-S., Kwak, C. H., … Gurbel, P. A. (2013). Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study. J Thromb Haemost, 11(6), 1194–1197. https://doi.org/10.1111/jth.12200
Jeong, Y. -. H., K. A. Abadilla, U. S. Tantry, Y. Park, J. -. S. Koh, C. H. Kwak, J. -. Y. Hwang, and P. A. Gurbel. “Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.” J Thromb Haemost 11, no. 6 (June 2013): 1194–97. https://doi.org/10.1111/jth.12200.
Jeong Y-H, Abadilla KA, Tantry US, Park Y, Koh J-S, Kwak CH, et al. Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study. J Thromb Haemost. 2013 Jun;11(6):1194–7.
Jeong, Y. .. H., et al. “Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study.” J Thromb Haemost, vol. 11, no. 6, June 2013, pp. 1194–97. Pubmed, doi:10.1111/jth.12200.
Jeong Y-H, Abadilla KA, Tantry US, Park Y, Koh J-S, Kwak CH, Hwang J-Y, Gurbel PA. Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study. J Thromb Haemost. 2013 Jun;11(6):1194–1197.
Published In
J Thromb Haemost
DOI
EISSN
1538-7836
Publication Date
June 2013
Volume
11
Issue
6
Start / End Page
1194 / 1197
Location
England
Related Subject Headings
- Ticlopidine
- Polymorphism, Single Nucleotide
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Pilot Projects
- Pharmacogenetics
- Percutaneous Coronary Intervention
- Odds Ratio
- Multivariate Analysis
- Middle Aged